1. United States Pharmacopeial Convention: United States Pharmacopoeia 30; National Formulary 25. US Pharmacopoeia Convention.
2. Gilman AG (2001) Goodman L S, Rall TW and Murad F “Goodman & Gilman’s The Pharmacological Basis of Therapeutics”, 10th edn. MacMillian Publishing Co., N.Y
3. Elumalai S, Aher K, Bhavar G (2011) Development and Validation of Rp-Hplc Method for Determination of Content Uniformity of Rabeprazole Sodium in Its Tablets Dosage Form. J Appl Pharm Sci 6:165–170
4. Osman A (2009) Spectrofluorometry, thin layer chromatography and column high-performance liquid chromatography determination of rabeprazole sodium in the presence of its acidic and oxidized degradation products J. AOACInt. 92:1373–1381.
5. Prasanna BR, Reddy MS (2009) Development and Validation of Rp-Hplc For The Determination of Rabeprazole Sodium in Pharmaceutical Formulations and Human Plasma. Asian J Res Chem 2:49–51